Inhibrx Biosciences Inc. (INBX)
NASDAQ: INBX
· Real-Time Price · USD
36.59
0.65 (1.81%)
At close: Oct 16, 2025, 3:59 PM
35.87
-1.98%
After-hours: Oct 16, 2025, 06:09 PM EDT
1.81% (1D)
| Bid | 34.27 |
| Market Cap | 530.08M |
| Revenue (ttm) | 1.4M |
| Net Income (ttm) | -163.69M |
| EPS (ttm) | -16.57 |
| PE Ratio (ttm) | -2.21 |
| Forward PE | -3.73 |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 40 |
| Volume | 97,914 |
| Avg. Volume (20D) | 126,020 |
| Open | 36.29 |
| Previous Close | 35.94 |
| Day's Range | 34.77 - 37.25 |
| 52-Week Range | 10.80 - 37.53 |
| Beta | 0.49 |
| Ex-Dividend Date | n/a |
About INBX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol INBX
Website n/a
5 months ago
+10.89%
Inhibrx Biosciences shares are trading higher afte...
Unlock content with
Pro Subscription
11 months ago · seekingalpha.com
Inhibrx Biosciences: Reincorporated And Trying To Find A Niche With Unique PlatformINBX's two main pipeline candidates, INBRX-109 and INBRX-106, are entering critical late-stage trials with data readouts expected in mid- to late-2025. INBRX-109 targets DR5 in solid tumors, showing p...